I Stopped Taking the Medication — Does That End My Claim?

Marin & MurphySuper Lawyers® 2014–2024(888) 348-2735

Ozempic (GLP-1) Lawsuit — Free Case Review

Your Stomach Symptoms Were Real

If you took brand-name Ozempic, Wegovy, or Rybelsus and were diagnosed with a tested, documented stomach injury with an ER or hospital visit, you may qualify.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.

Did this happen to you — or someone you love?

Start your free case reviewTell us anyway

Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.

(888) 348-2735

Partners

Matthew T. Marin & Stefanie A. Murphy

Super Lawyers® honorees · American Association for Justice members

Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.

No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.

Not by itself. For NAION vision-loss claims, stopping the medication has no effect on eligibility: the criteria accept a diagnosis made while taking the drug or after stopping it, with no stated cutoff. For stomach-injury claims, the criteria require that the diagnosis was made while you were taking the medication or within about 30 days of stopping — so what matters is the date of your diagnosis, not the fact that you eventually came off the drug.

What the 30-day window actually measures

People read the 30-day rule as a deadline for calling a lawyer. It is not. It is a rule about when the diagnosis was made, and it was fixed on the day your doctor made it.

The criteria ask whether gastroparesis or gastric obstruction was diagnosed while you were taking a brand-name GLP-1 or within roughly 30 days after your last dose. If your diagnosis came during use — the most common pattern — that element is satisfied no matter how long ago you stopped. The window connects the diagnosis to the exposure. It is not a limit on how long you have to ask.

Where stopping does cause a problem

One pattern the rule genuinely affects: symptoms began during use, you came off the medication, and you were not formally diagnosed until months or years later. That happens often — particularly to people told for a long stretch that nothing was wrong, or that it was an eating disorder, or that it was in their head. Delayed diagnosis here is common and it is not the patient’s doing.

If that describes you, the gap between last dose and diagnosis is what will be examined. It is also the thing most often clarified by records rather than memory — a chart note, a referral, an imaging order, or an earlier working diagnosis can sit closer to the medication than a person remembers. Tell us the sequence and let the records settle the dates. A near-miss goes to a closer review, not to an automatic no.

NAION: stopping changes nothing

The NAION criteria are explicit that a diagnosis qualifies whether made while taking the medication or after stopping, and they state no outer time limit on the diagnosis date. Someone who took Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, or Zepbound, stopped, and was later diagnosed with NAION is not excluded on timing grounds. The criteria do require an actual NAION diagnosis and some degree of permanent vision impairment, together with brand-name use.

That is a criteria question only. Every state also sets its own filing deadline, and those apply to both tracks regardless of what screening criteria say.

An honest note about symptoms that did not go away

A great many people describe the same thing: they stopped the medication and never went back to normal. That experience is real and widely reported. It is also one of the specific points the manufacturers are contesting — they have moved to exclude expert opinion that drug-related gastroparesis persists after the medication is discontinued and cleared from the body, as part of the briefing for the Rule 702 hearing held September 14 through 18, 2026.

We say so because it is true, and because it explains why documentation of the period after stopping matters as much as documentation from during use. Follow-up visits, repeat testing, weight records, nutrition consults, and hospital admissions after the last dose are the record of persistence.

What to gather now that you are off it

• Last-dose month and year, as precisely as you can, for each brand you took.
• Pharmacy records. A fill-history printout is the cleanest proof of which brand you took and when, and any pharmacy will produce one on request.
• Diagnosis month and year, and whether a gastric emptying study was performed. “I’m not sure what tests I had” is a normal answer.
• ER and hospital dates connected to the injury.
• Records from after you stopped — follow-up appointments, repeat testing, ongoing treatment.
• Physical items you still have: pens, boxes, packaging, receipts, letters and emails.

Common questions

Common questions: can you sue?, it’s not about your doctor, still taking Ozempic?, is it too late to file?, still on a GLP-1, switched drugs, calling for a parent, and how compensation works.